Methods for the Treatment of Trinucleotide Repeat Expansion Disorders Associated with FAN1 activity via Targeting of FAN1 Splice Site Inhibitory Sequences

Compositions and methods thereof for increasing endogenous FAN1 expression in a target cell are provided. Preferably, compositions include one or more splice switching antisense oligonucleotides targeting FAN1 exon 10-intron 10-exon 11 junction. The compositions are effective in increasing levels of functional FAN1 mRNA transcripts encoding FAN1 derived from the pre-mRNA in a target cell. The compositions and methods are particularly suited for treating, ameliorating, or delaying the onset of a trinucleotide repeat expansion disorder in a subject in need thereof.

Departments: Department of Biology, David H Koch Institute for Integrative Cancer Res
Technology Areas: Biotechnology: DNA & RNA Editing / Drug Discovery and Research Tools: Genomics & Proteomics / Therapeutics: Nucleic Acids
Impact Areas: Healthy Living

  • compositions and methods for treating fan1 associated trinucleotide repeat expansion disorders
    Patent Cooperation Treaty | Published application
  • compositions and methods for treating fan1 associated trinucleotide repeat expansion disorders
    European Patent Convention | Pending
  • compositions and methods for treating fan1 associated trinucleotide repeat expansion disorders
    United States of America | Published application

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies